NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
April 09 2024 - 7:00AM
Business Wire
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology
testing services company, today announced that it will report its
first quarter 2024 financial results on Tuesday, April 30, 2024.
Company management will host a webcast and conference call that
morning at 8:30 a.m. Eastern Time to discuss financial results and
recent highlights.
The live webcast may be accessed by visiting the Investor
Relations section of our website at ir.neogenomics.com. The webcast
will be archived and available for replay shortly after the
conclusion of the call.
To access the live call via telephone, dial (877) 545-0523
(domestic) or (973) 528-0016 (international) at least five minutes
prior to the call. The participant access code is 700733.
About NeoGenomics, Inc.
NeoGenomics, Inc. specializes in cancer genetics testing and
information services, providing one of the most comprehensive
oncology-focused testing menus in the world for physicians to help
them diagnose and treat cancer. The Company's Pharma Services
Division serves pharmaceutical clients in clinical trials and drug
development.
Headquartered in Fort Myers, FL, NeoGenomics operates CAP
accredited and CLIA certified laboratories for full-service sample
processing in Fort Myers, Florida; Aliso Viejo and San Diego,
California; Research Triangle Park, North Carolina; and Houston,
Texas; and a CAP accredited full-service, sample-processing
laboratory in Cambridge, United Kingdom. NeoGenomics also has
several, small, non-processing laboratory locations across the
United States for providing analysis services. NeoGenomics serves
the needs of pathologists, oncologists, academic centers, hospital
systems, pharmaceutical firms, integrated service delivery
networks, and managed care organizations throughout the United
States, and pharmaceutical firms in Europe and Asia.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240409558333/en/
Investor Contact Kendra Sweeney
kendra.sweeney@neogenomics.com
Media Contact Andrea Sampson
asampson@sampsonprgroup.com
NeoGenomics (NASDAQ:NEO)
Historical Stock Chart
From Jun 2024 to Jul 2024
NeoGenomics (NASDAQ:NEO)
Historical Stock Chart
From Jul 2023 to Jul 2024